Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02018523
What this trial is testing

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jun Zhang 7
Testing effectiveness (Phase 2)Ended earlyNCT04856176
What this trial is testing

Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4
Tufts Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT02705820
What this trial is testing

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Bank of Cyprus Oncology Centre 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04995523
What this trial is testing

AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 212
Large-scale testing (Phase 3)UnknownNCT05673590
What this trial is testing

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 612
Testing effectiveness (Phase 2)Study completedNCT00005989
What this trial is testing

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Testing effectiveness (Phase 2)Looking for participantsNCT06896890
What this trial is testing

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (advanced Non-small Cell Lung Cancer)Stage IV Lung Cancer
Inhatarget Therapeutics 32
Testing effectiveness (Phase 2)Study completedNCT04623775
What this trial is testing

Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerMetastatic Non-small Cell Lung Cancer
Bristol-Myers Squibb 468
Large-scale testing (Phase 3)UnknownNCT05042375
What this trial is testing

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT04880863
What this trial is testing

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
NeoTX Therapeutics Ltd. 38
Not applicableUnknownNCT05996263
What this trial is testing

Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)

Who this might be right for
Lung Cancer Stage IIILung Cancer Stage IV
University Hospital, Brest 75
Testing effectiveness (Phase 2)Study completedNCT00702975
What this trial is testing

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerNSCLC
Radboud University Medical Center 35
Large-scale testing (Phase 3)Study completedNCT00976456
What this trial is testing

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
PD Dr. med. Wolfgang Schuette 271
Testing effectiveness (Phase 2)Study completedNCT02289456
What this trial is testing

Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04310007
What this trial is testing

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 117
Early research (Phase 1)Study completedNCT02451930
What this trial is testing

The Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
Eli Lilly and Company 71
Testing effectiveness (Phase 2)Ended earlyNCT01640730
What this trial is testing

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Who this might be right for
Stage IV NSCLC
KangLaiTe USA 1
Next Page